NASDAQ:DOX

Amdocs Stock Forecast, Price & News

$77.85
-1.39 (-1.75 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$77.30
$78.35
50-Day Range
$72.68
$80.84
52-Week Range
$54.68
$82.38
Volume1.64 million shs
Average Volume852,692 shs
Market Capitalization$10.21 billion
P/E Ratio15.26
Dividend Yield1.82%
Beta0.78
30 days | 90 days | 365 days | Advanced Chart
Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for Amdocs and its competitors with MarketBeat's FREE daily newsletter.


Amdocs logo

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services to the communications, cable and satellite, entertainment, and media industry service providers worldwide. The company offers a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support and operations, such as end-to-end systems integration, managed, testing, cloud, digital business operations, and consulting services that addresses service providers business imperatives, including consumer experience and monetization, media and digital services, enterprise and connected society, open cloud networks, new domains and disruptions, and services and hybrid operations. It also provides revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform. In addition, the company offers advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.38 out of 5 stars

Computer And Technology Sector

24th out of 1,586 stocks

Custom Computer Programming Services Industry

1st out of 47 stocks

Analyst Opinion: 1.5Community Rank: 2.9Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Amdocs (NASDAQ:DOX) Frequently Asked Questions

Is Amdocs a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs
or view top-rated stocks.

What stocks does MarketBeat like better than Amdocs?

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Amdocs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Amdocs' next earnings date?

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Amdocs
.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings results on Tuesday, May, 11th. The technology company reported $1.13 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $1.13. The technology company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.04 billion. Amdocs had a net margin of 15.98% and a trailing twelve-month return on equity of 15.28%. The business's quarterly revenue was up .1% on a year-over-year basis. During the same period last year, the business posted $1.08 EPS.
View Amdocs' earnings history
.

How has Amdocs' stock price been impacted by COVID-19 (Coronavirus)?

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DOX stock has increased by 26.8% and is now trading at $77.85.
View which stocks have been most impacted by COVID-19
.

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs announced a quarterly dividend on Wednesday, May 12th. Investors of record on Wednesday, June 30th will be given a dividend of $0.36 per share on Friday, July 23rd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date is Tuesday, June 29th.
View Amdocs' dividend history
.

Is Amdocs a good dividend stock?

Amdocs pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.82%. Amdocs has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 34.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 29.33% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided EPS guidance of $4.710-4.840 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.710. The company issued revenue guidance of $4.21 billion-4.34 billion, compared to the consensus revenue estimate of $4.24 billion.

What price target have analysts set for DOX?

2 equities research analysts have issued 1-year price objectives for Amdocs' shares. Their forecasts range from $75.00 to $87.00. On average, they expect Amdocs' share price to reach $82.00 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts' price targets for Amdocs
or view top-rated stocks among Wall Street analysts.

Who are Amdocs' key executives?

Amdocs' management team includes the following people:
  • Mr. Joshua Sheffer, Pres, CEO & Director (Age 61)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 50)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 49)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media
  • Mr. Oren Marmur, Head of NFV - Amdocs Open Network
  • Mr. Rajat Raheja, Division Pres of Amdocs Devel. Center India Pvt. Ltd (Age 52)
  • Anthony Goonetilleke, Group Pres of Media, Network & Technology

What is Shuky Sheffer's approval rating as Amdocs' CEO?

915 employees have rated Amdocs CEO Shuky Sheffer on Glassdoor.com. Shuky Sheffer has an approval rating of 90% among Amdocs' employees.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Who are Amdocs' major shareholders?

Amdocs' stock is owned by many different institutional and retail investors. Top institutional shareholders include Janus Henderson Group PLC (5.27%), Massachusetts Financial Services Co. MA (4.09%), LSV Asset Management (3.93%), Pzena Investment Management LLC (3.41%), BlackRock Inc. (3.17%) and Nordea Investment Management AB (2.39%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, LSV Asset Management, Alyeska Investment Group L.P., Arrowstreet Capital Limited Partnership, Prudential Financial Inc., Lazard Asset Management LLC, Clearbridge Investments LLC, and Robeco Institutional Asset Management B.V..

Which institutional investors are buying Amdocs stock?

DOX stock was bought by a variety of institutional investors in the last quarter, including Pzena Investment Management LLC, Russell Investments Group Ltd., Morgan Stanley, BlackRock Inc., Point72 Asset Management L.P., Goldman Sachs Group Inc., Envestnet Asset Management Inc., and Clal Insurance Enterprises Holdings Ltd.

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $77.85.

How much money does Amdocs make?

Amdocs has a market capitalization of $10.21 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis.

How many employees does Amdocs have?

Amdocs employs 25,875 workers across the globe.

Does Amdocs have any subsidiaries?

The following companies are subsidiares of Amdocs: AMDOCS (AUSTRALIA) PTY LTD, AMDOCS (CR) s.r.o., AMDOCS (ITALY) SRL, AMDOCS (PORTUGAL) SOFTWARE UNIPESSOAL LDA, AMDOCS (UK) LIMITED, AMDOCS ASTRUM LIMITED, AMDOCS BRASIL LTDA, AMDOCS BULGARIA EOOD, AMDOCS DEVELOPMENT CENTRE INDIA LLP, AMDOCS DEVELOPMENT LIMITED, AMDOCS ECUADOR S.A., AMDOCS FRANCE, AMDOCS HELLAS LTD, AMDOCS HONG KONG LIMITED, AMDOCS INVESTMENTS SWITZERLAND LIMITED, AMDOCS MANAGEMENT LIMITED, AMDOCS MONTENEGRO D.O.O., AMDOCS PERU S.A.C., AMDOCS PHILIPPINES INC., AMDOCS SINGAPORE PTE. LTD., AMDOCS SOFTWARE GmbH, AMDOCS SPAIN SLU, AMDOCS SYSTEMS EUROPE LIMITED, AMDOCS SYSTEMS GROUP LIMITED, AMDOCS SYSTEMS LIMITED, AMDOCS TETHYS LIMITED, AMDOCS VIETNAM COMPANY LIMITED, AMDOCS YAZILIM HIZMETLERI ANONIM SIRKETI, Actix, Amdocs (Finland) Oy, Amdocs Advertising And Media - Emea ApS, Amdocs B.V., Amdocs Canadian Managed Services Inc, Amdocs Champaign Inc., Amdocs Chile SpA, Amdocs Costa Rica SR Ltda, Amdocs Inc., Amdocs International GmbH, Amdocs México S. de R.L. de C.V., Amdocs Qpass Inc., Amdocs Software Megoldások Korlátolt Felelosségu Társaság, Amdocs Software Services Américas S. de R.L. de C.V., Amdocs Software Technologies Inc, Amdocs Systems AB, BRITE:BILL GROUP LIMITED, Bridgewater Systems, Brite:Bill, CRAMER LIMITED, Celcite, Changingworlds, Cramer Systems, DST Innovis, ECHOS SERVICOS SA, EUROPEAN SOFTWARE MARKETING LTD, EUROPEAN SUPPORT LIMITED, Hungarian Innovation Systems Korlátolt Felelosségu Társaság, IGNIS UK INVESTMENT LIMITED, INVENTIS DEVELOPMENTS LIMITED, Jacobs Rimell Ltd., MX Telecom, OPENMARKET LIMITED, OPENMARKET PTY LTD, ORBIS INVESTMENT LTD, Openet, Openmarket Inc., Opis Investment Switzerland GmbH, PT. AMDOCS INDONESIA, PT. APPLICATION SOLUTIONS, PT. SOFTWARE SOLUTIONS INDONESIA, Pontis, Projekt202 LLC, Qpass, Solect Technology Group, Streamezzo, Telecom Technology Services, UNIVERSUM INVESTMENTS LTD, UTIBA PTE LTD, UTIBA SOFTWARE SOLUTIONS (SINGAPORE) PTE. LTD., UXP Systems GmbH, UXP Systems Inc, Vindicia, Vubiquity, XACCT Technologies, cVidya, and jNetX.

When was Amdocs founded?

Amdocs was founded in 1982.

What is Amdocs' official website?

The official website for Amdocs is www.amdocs.com.

Where are Amdocs' headquarters?

Amdocs is headquartered at 1390 Timberlake Manor Parkway, Chesterfield MO, 63017.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at (314) 212-7000 or via email at [email protected]


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.